Bernd R. Seizinger, Director at Aprea Therapeutics, Inc. (APRE), bought 50,000 shares at $0.71 ($36K) on 2022-05-18, disclosed to the SEC on 2022-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| APRE | BUY | 2024-10-15 | $27K | — | Filing → |
| APRE | BUY | 2024-03-14 | $100K | — | Filing → |
| APTO | BUY | 2023-09-25 | $53K | — | Filing → |